ID: ALA5078057

Max Phase: Preclinical

Molecular Formula: C21H27ClN8OS

Molecular Weight: 475.02

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)N1CCc2nc(NC(=O)[C@H]3CC[C@@H](n4cnc5c(N)nc(Cl)nc54)CC3)sc2C1

Standard InChI:  InChI=1S/C21H27ClN8OS/c1-11(2)29-8-7-14-15(9-29)32-21(25-14)28-19(31)12-3-5-13(6-4-12)30-10-24-16-17(23)26-20(22)27-18(16)30/h10-13H,3-9H2,1-2H3,(H2,23,26,27)(H,25,28,31)/t12-,13+

Standard InChI Key:  INNUMQBLJSNDFL-BETUJISGSA-N

Associated Targets(Human)

Choline kinase alpha 330 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Choline/ethanolamine kinase 45 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 475.02Molecular Weight (Monoisotopic): 474.1717AlogP: 3.65#Rotatable Bonds: 4
Polar Surface Area: 114.85Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.93CX Basic pKa: 7.14CX LogP: 2.94CX LogD: 2.99
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.55Np Likeness Score: -1.66

References

1. Quartieri F, Nesi M, Avanzi NR, Borghi D, Casale E, Corti E, Cucchi U, Donati D, Fasolini M, Felder ER, Galvani A, Giorgini ML, Lomolino A, Menichincheri M, Orrenius C, Perrera C, Re Depaolini S, Riccardi-Sirtori F, Salsi E, Isacchi A, Gnocchi P..  (2021)  Identification of unprecedented ATP-competitive choline kinase inhibitors.,  51  [PMID:34416377] [10.1016/j.bmcl.2021.128310]

Source